BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23589412)

  • 1. Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients.
    Gossec L; Salejan F; Nataf H; Nguyen M; Gaud-Listrat V; Hudry C; Breuillard P; Dernis E; Boumier P; Durandin-Truffinet M; Fannius J; Fechtenbaum J; Izou-Fouillot MA; Labatide-Alanore S; Lebrun A; LeDevic P; LeGoux P; Sacchi A; Salliot C; Sparsa L; d'André FL; Dougados M;
    Arthritis Care Res (Hoboken); 2013 May; 65(5):712-7. PubMed ID: 23589412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of rheumatologists vis-à-vis assessment of traditional cardiovascular risk factors in rheumatoid arthritis.
    Luck Y; Baron M; Bardakjian S; Berkson L; Buchignani M; Fallavolita S; Giac F; Gyger G; Tatibouet S; Hudson M
    Clin Rheumatol; 2014 Jun; 33(6):769-74. PubMed ID: 24526251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors that impact decision making among rheumatologists in the initiation of treatment for hypertension in rheumatoid arthritis.
    Nguyen-Oghalai TU; Hunnicutt SE; Smith ST; Maganti R; McNearney TA
    J Clin Rheumatol; 2007 Dec; 13(6):307-12. PubMed ID: 18176137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current limitations in the management of cardiovascular risk in rheumatoid arthritis.
    Scott IC; Ibrahim F; Johnson D; Scott DL; Kingsley GH
    Clin Exp Rheumatol; 2012; 30(2):228-32. PubMed ID: 22325679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
    Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
    Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis.
    Gonzalez-Gay MA; Gonzalez-Juanatey C; Lopez-Diaz MJ; Piñeiro A; Garcia-Porrua C; Miranda-Filloy JA; Ollier WE; Martin J; Llorca J
    Arthritis Rheum; 2007 Feb; 57(1):125-32. PubMed ID: 17266100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
    Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
    Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining rheumatologists' accuracy at assessing functional disability in rheumatoid arthritis patients using the Health Assessment Questionnaire-Disability Index.
    Carter JD; Lodhi AB; Nagda SR; Ricca L; Ward C; Traina E; Thompson ZJ; Huang Y; Valeriano J; Vasey FB
    J Rheumatol; 2007 May; 34(5):958-63. PubMed ID: 17407221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular death in rheumatoid arthritis: a population-based study.
    Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.
    Arts EE; Popa C; Den Broeder AA; Semb AG; Toms T; Kitas GD; van Riel PL; Fransen J
    Ann Rheum Dis; 2015 Apr; 74(4):668-74. PubMed ID: 24389293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk assessment in rheumatoid arthritis: impact of the EULAR recommendations on a national calibrated score risk index.
    Rosales-Alexander JL; Salvatierra J; Llorca J; Magro-Checa C; González-Gay MA; Cantero-Hinojosa J; Raya-Álvarez E
    Clin Exp Rheumatol; 2014; 32(2):237-42. PubMed ID: 24388041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.
    Peters MJ; Symmons DP; McCarey D; Dijkmans BA; Nicola P; Kvien TK; McInnes IB; Haentzschel H; Gonzalez-Gay MA; Provan S; Semb A; Sidiropoulos P; Kitas G; Smulders YM; Soubrier M; Szekanecz Z; Sattar N; Nurmohamed MT
    Ann Rheum Dis; 2010 Feb; 69(2):325-31. PubMed ID: 19773290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?
    Gabriel SE; Wagner JL; Zinsmeister AR; Scott CG; Luthra HS
    Arthritis Rheum; 2001 Jul; 44(7):1504-14. PubMed ID: 11465700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease assessment in rheumatoid arthritis: a guide to translating knowledge of cardiovascular risk into clinical practice.
    Semb AG; Rollefstad S; van Riel P; Kitas GD; Matteson EL; Gabriel SE
    Ann Rheum Dis; 2014 Jul; 73(7):1284-8. PubMed ID: 24608403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical inactivity and arterial dysfunction in patients with rheumatoid arthritis.
    Crilly MA; Wallace A
    Scand J Rheumatol; 2013; 42(1):27-33. PubMed ID: 22839595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of dyslipidemia and elevated cardiovascular risk in patients with rheumatoid arthritis].
    Haye Salinas MJ; Bertoli AM; Lema L; Saucedo C; Rosa J; Quintana R; Bellomio V; Aguero S; Spindler W; Tamborenea MN; Schimid M; Ceccato F; Sala JP; Paira S; Spindler A; Soriano ER; Estel BA; Caeiro F; Alvarellos A; Saurit V
    Medicina (B Aires); 2013; 73(1):26-30. PubMed ID: 23335702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of co-morbidities and evaluation of their monitoring in Korean patients with rheumatoid arthritis: comparison with the results of an international, cross-sectional study (COMORA).
    Choi IA; Park SH; Cha HS; Park W; Kim HA; Yoo DH; Baek HJ; Lee SG; Lee YJ; Park YB; Shim SC; Hmamouchi I; Song YW
    Int J Rheum Dis; 2018 Jul; 21(7):1414-1422. PubMed ID: 28261976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care.
    Emanuel G; Charlton J; Ashworth M; Gulliford MC; Dregan A
    Heart; 2016 Dec; 102(24):1957-1962. PubMed ID: 27534979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.